Catalyst

Slingshot members are tracking this event:

Portola (PTLA) Expects FDA Decision on Andexxa (Andexanet Alfa) on May 4, 2018

Source Link:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2293923

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTLA
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Initially expected by the end of 2017, the BLA has been resubmitted with a PDUFA date of February 2, 2018
http://investors.por...
Additional Relevant Details Update on Dec 24 2017: Date extension from Feb 2 2018 to May 4 2018.
https://seekingalpha...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
May 03, 2018
Occurred Source:
http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle&ID=2347018
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Fda Decision, Andexxa, Serious Uncontrolled Bleeding Event, Urgent, Emergent Surgery, Andexanet Alfa
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.